Literature DB >> 11198378

On the schistosomicidal effect of triclabendazole an experimental study.

S S Khalil1.   

Abstract

Mice were infected with S. mansoni cercariae and divided to three groups: one as control, the others were treated with a single oral dose of PZQ or TCBZ. The efficacy of the drugs was evaluated on the basis of egg excretion, number, sex and distribution of worms, oogram changes and tissue egg load. Results demonstrated that eggs disappeared from the stools in both treated groups, all worms died in the PZQ treated group while in the TCBZ group, worm production amounted to 84%. Male worms were more susceptible to the two drugs, they died earlier. On the fourth week after TCBZ, the few surviving worms returned back from their hepatic shift to the mesenteric veins. By studying the oogram pattern, it was found that PZQ had a direct lethal effect on the mature eggs; TCBZ had a lower effect on egg viability but the oogram findings indicated cessation of egg laying.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11198378

Source DB:  PubMed          Journal:  J Egypt Soc Parasitol        ISSN: 1110-0583


  3 in total

1.  Effect of a novel benzimidazole derivative in experimental Schistosoma mansoni infection.

Authors:  Serry A El Bialy; Amira Taman; Samar N El-Beshbishi; Basem Mansour; Mohamed El-Malky; Waleed A Bayoumi; Hassan M Essa
Journal:  Parasitol Res       Date:  2013-10-06       Impact factor: 2.289

2.  Use of triclabendazole for treatment of patients co-infected by Fasciola spp. and S. mansoni in Behera Governorate, Egypt.

Authors:  Paolo Barduagni; Yehia Hassanein; Mostafa Mohamed; Aly El Wakeel; Mabrouk El Sayed; Zuhair Hallaj; Filippo Curtale
Journal:  Parasitol Res       Date:  2007-12-12       Impact factor: 2.289

3.  Antiparasitic Activity of Mirazid, Myrrh Total Oil and Nitazoxanide Compared to Praziquantel on Schistosoma mansoni: Scanning Electron Microscopic Study.

Authors:  Mona El-Sayad; Sahar Abu Helw; Hend El-Taweel; Mohammad Aziz
Journal:  Iran J Parasitol       Date:  2017 Jul-Sep       Impact factor: 1.012

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.